Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2013 3
2014 4
2015 3
2016 1
2017 2
2018 5
2019 5
2020 12
2021 12
2022 11
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Clinical application of the AMOY 9-in-1 panel to lung cancer patients.
Kunimasa K, Matsumoto S, Kawamura T, Inoue T, Tamiya M, Kanzaki R, Maniwa T, Okami J, Honma K, Goto K, Nishino K. Kunimasa K, et al. Among authors: kawamura t. Lung Cancer. 2023 May;179:107190. doi: 10.1016/j.lungcan.2023.107190. Epub 2023 Apr 8. Lung Cancer. 2023. PMID: 37058787 Free article.
Moraxella catarrhalis bacteremic pneumonia.
Anezaki H, Terada N, Kawamura T, Kurai H. Anezaki H, et al. Among authors: kawamura t. IDCases. 2020 Feb 5;19:e00712. doi: 10.1016/j.idcr.2020.e00712. eCollection 2020. IDCases. 2020. PMID: 32082989 Free PMC article.
Immunohistochemical analysis of B7-H3 expression in patients with lung cancer following various anti-cancer treatments.
Omori S, Muramatsu K, Kawata T, Miyawaki E, Miyawaki T, Mamesaya N, Kawamura T, Kobayashi H, Nakashima K, Wakuda K, Ono A, Kenmotsu H, Naito T, Murakami H, Sugino T, Takahashi T. Omori S, et al. Among authors: kawamura t. Invest New Drugs. 2023 Apr;41(2):356-364. doi: 10.1007/s10637-023-01353-8. Epub 2023 Apr 10. Invest New Drugs. 2023. PMID: 37036580
Crizotinib-induced simultaneous multiple cardiac toxicities.
Oyakawa T, Muraoka N, Iida K, Kusuhara M, Kawamura T, Naito T, Takahashi T. Oyakawa T, et al. Among authors: kawamura t. Invest New Drugs. 2018 Oct;36(5):949-951. doi: 10.1007/s10637-018-0605-x. Epub 2018 May 2. Invest New Drugs. 2018. PMID: 29717400
Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA Study.
Murata Y, Tanzawa S, Misumi T, Yoshioka H, Miyauchi E, Ninomiya K, Takeshita M, Ito K, Okamoto T, Sugawara S, Kawashima Y, Hashimoto K, Mori M, Miyanaga A, Hayashi A, Tanaka H, Honda R, Nojiri M, Sato Y, Hata A, Masuda K, Kozuki T, Kawamura T, Suzuki T, Yamaguchi T, Asada K, Tetsumoto S, Tanaka H, Watanabe S, Umeda Y, Yamaguchi K, Kuyama S, Tsuruno K, Misumi Y, Kuraishi H, Yoshihara K, Nakao A, Kubo A, Yokoyama T, Watanabe K, Seki N. Murata Y, et al. Among authors: kawamura t. JTO Clin Res Rep. 2023 Oct 20;4(12):100593. doi: 10.1016/j.jtocrr.2023.100593. eCollection 2023 Dec. JTO Clin Res Rep. 2023. PMID: 38046378 Free PMC article.
Improvement strategies for successful next-generation sequencing analysis of lung cancer.
Kunimasa K, Matsumoto S, Nishino K, Nakamura H, Kuhara H, Tamiya M, Inoue T, Kawamura T, Kawachi H, Kuno K, Kimura T, Maniwa T, Okami J, Nakatsuka SI, Goto K, Kumagai T. Kunimasa K, et al. Among authors: kawamura t. Future Oncol. 2020 Aug;16(22):1597-1606. doi: 10.2217/fon-2020-0332. Epub 2020 Jun 3. Future Oncol. 2020. PMID: 32490705 Free article.
60 results